Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Coala Life - Refilled growth capital

Coala-Life Group

Redeye updates its estimates and valuation following Coala Life’s recent rights issue, securing cSEK55m in growth capital and resulting in a 75% dilution for non-participating shareholders. CEO Dan Pitulia continues to demonstrate his commitment by investing SEK7m in the rights issue. Our revised estimates reflect the recent development in patient ramp-up for remote monitoring (PRM) and the announced cost-saving program. In our updated valuation, we also factor in an anticipated cash injection of SEK12m from the warrants due in Q2 2024 -our new Base case is SEK0.12 (SEK1.3) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Coala Life - Refilled growth capital

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.